3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Melanoma
1
Intracranial Aneurysm
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Breast Cancer Female
1
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Standard of Care
1
Sodium Chloride
1
Self-Help Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Cancer Female
×
Anesthesia, Conduction
×
Clear all
NCT03779685
2020-08-05
GENEXAN
Azienda Ospedaliera San Gerardo di Monza
Phase NA
Unknown
100 enrolled